English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The association between serum uric acid (SUA) levels and the risk for vascular disease is controversial. Several studies in the general population suggested that elevated SUA levels are independently related to increased vascular mor- bidity and mortality. However, in other studies this relationship was not significant when other vascular risk factors were considered. Some evidence also suggests that uric acid might be implicated in the development of hypertension, renal dis- ease and insulin resistance. We review the epidemiological data on the relationship between SUA levels and vascular dis- ease and summarize the potential adverse vascular effects of uric acid. We also discuss the associations of SUA levels with established vascular risk factors and the potential benefits of lowering SUA concentration. It is unclear whether uric acid is a causal risk factor for vascular disease. Until more conclusive data are available, patients with elevated SUA lev- els should be evaluated for the presence of more established risk factors (including type 2 diabetes mellitus, metabolic syndrome and chronic kidney disease) and treatment should be targeted against these factors.

Pitfalls in the Evaluation of Uric Acid as a Risk Factor for Vascular Disease~!2009-10-29~!2009-12-23~!2010-04-08~!